Orion Infusion Limited (DSE:ORIONINFU)
Bangladesh · Delayed Price · Currency is BDT 219.30
+14.20 (6.92%)
At close: Nov 4, 2026
Orion Infusion Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 4,465 | 6,387 | 9,783 | 6,851 | 1,777 | 1,395 | |
Market Cap Growth | -51.35% | -34.71% | 42.79% | 285.45% | 27.45% | -4.99% |
Enterprise Value | 4,741 | 6,673 | 10,056 | 7,155 | 3,585 | 1,667 |
Last Close Price | 219.30 | 312.09 | 476.14 | 332.35 | 85.90 | 66.58 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 125.73 | 182.36 | 231.09 | 163.51 | 41.51 | 50.02 |
PS Ratio | 6.90 | 9.61 | 11.82 | 8.46 | 2.14 | 1.92 |
PB Ratio | 13.53 | 19.59 | 31.09 | 23.49 | 6.14 | 5.23 |
P/TBV Ratio | 13.53 | 19.59 | 31.09 | 23.49 | 6.14 | 5.23 |
P/FCF Ratio | 67.67 | 309.08 | 212.49 | - | 68.34 | 217.25 |
P/OCF Ratio | 66.93 | 241.43 | 170.28 | 112.93 | 39.11 | 48.87 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EV/Sales Ratio | 7.32 | 10.04 | 12.15 | 8.83 | 4.32 | 2.29 |
EV/EBITDA Ratio | 55.37 | 69.16 | 101.06 | 76.27 | 34.80 | 18.28 |
EV/EBIT Ratio | 64.26 | 79.36 | 119.51 | 91.24 | 38.73 | 20.56 |
EV/FCF Ratio | 71.85 | 322.95 | 218.42 | - | 137.84 | 259.65 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Debt / Equity Ratio | 0.90 | 0.98 | 1.01 | 1.27 | 1.14 | 1.10 |
Debt / EBITDA Ratio | 3.45 | 3.11 | 2.96 | 3.60 | 2.92 | 2.89 |
Debt / FCF Ratio | 4.48 | 15.53 | 6.92 | - | 12.65 | 45.74 |
Net Debt / Equity Ratio | 0.84 | 0.93 | 0.92 | 1.10 | 1.00 | 1.04 |
Net Debt / EBITDA Ratio | 3.50 | 3.13 | 2.92 | 3.42 | 2.80 | 3.05 |
Net Debt / FCF Ratio | 4.18 | 14.62 | 6.31 | -44.16 | 11.08 | 43.28 |
Asset Turnover | 0.77 | 0.80 | 1.00 | 1.02 | 1.16 | 1.06 |
Inventory Turnover | 2.79 | 2.88 | 3.73 | 4.23 | 5.03 | 5.13 |
Quick Ratio | 0.35 | 0.34 | 0.30 | 0.35 | 0.43 | 0.41 |
Current Ratio | 0.97 | 0.94 | 0.91 | 0.86 | 0.95 | 0.89 |
Return on Equity (ROE) | 10.93% | 10.93% | 13.96% | 14.42% | 15.39% | 10.63% |
Return on Assets (ROA) | 5.47% | 6.29% | 6.33% | 6.15% | 8.08% | 7.37% |
Return on Invested Capital (ROIC) | 9.73% | 10.74% | 11.34% | 10.85% | 10.68% | 7.61% |
Return on Capital Employed (ROCE) | 20.40% | 23.70% | 24.70% | 23.90% | 27.40% | 26.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Earnings Yield | 0.80% | 0.55% | 0.43% | 0.61% | 2.41% | 2.00% |
FCF Yield | 1.48% | 0.32% | 0.47% | -0.11% | 1.46% | 0.46% |
Dividend Yield | 0.91% | 0.64% | 0.25% | 0.30% | 2.29% | 1.46% |
Payout Ratio | 128.43% | 67.84% | 41.41% | 57.90% | 59.14% | 52.21% |
Total Shareholder Return | 0.91% | 0.64% | 0.25% | 0.30% | 2.29% | 1.46% |